- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03069027
Efficacy of External Nasal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries
December 23, 2017 updated by: Dr. Mohamed Ibrahim, Al Jedaani Hospital
Efficacy of External Nasal Nerve Block on Postoperative Agitation Following Nasal Surgeries Under General Anesthesia. Randomized, Controlled Trial
Emergence agitation following general anaesthesia may lead to serious complications like self-extubation or removal of catheters, which can lead to hypoxia, aspiration pneumonia, bleeding or reoperation.
Nose surgery is associated with a higher incidence of emergence agitation.
The investigators planned to evaluate the efficacy of external nasal nerve block in prevention of postoperative agitation following external nasal surgeries under general anesthesia(GA).
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Meccah
-
Jeddah, Meccah, Saudi Arabia, 21462/7500
- Al Jedaani group of hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 110 adult patients of ASA physical status I and II,
- Age 20-60 years,
- Scheduled for elective external nasal surgeries in which nasal packing on each side was used postoperatively for 24 hours.
Exclusion Criteria:
- History of uncontrolled hypertension,
- Ischemic or valvular heart disease,
- Use of MAO inhibitors or adrenergic blocking drugs,
- Cognitive impairment,
- Patients taking antipsychotics,
- Renal insufficiency or liver dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Group I(control)
patients allocated for external nasal nerve block with saline adrenaline 1/200,000 (placebo)
|
Three single (midline injection) and 4 paired (bilateral injection) sites to block the external nasal sensation.
|
Active Comparator: Group II(block)
'External nasal nerve block by Xylocaine, adrenaline'
|
Three single (midline injection) and 4 paired (bilateral injection) sites to block the external nasal sensation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative agitation
Time Frame: Emergence is defined as the time interval from discontinuation of anesthesia to 5 min after extubation.
|
Assessment done using Richmond agitation- sedation scale (RASS)
|
Emergence is defined as the time interval from discontinuation of anesthesia to 5 min after extubation.
|
Quality of recovery
Time Frame: 24 hours postoperative
|
Quality of recovery
|
24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dose of fentanyl
Time Frame: intraoperative period in minutes
|
Fentanyl boluses were given in response to changes in hemodynamics (more than 15% increases in MAP and HR than the baseline values taken after induction by 5 minutes)
|
intraoperative period in minutes
|
morphine dose in PACU
Time Frame: one hour in PACU
|
equivalent morphine dose in PACU (calculated using opioid:morphine equivalents of 100 µg i.v.
fentanyl to 10 mg i.v.
morphine; 75- 100 mg IV pethidine to 10 mg i.v.
morphine
|
one hour in PACU
|
Nausea and vomiting in PACU
Time Frame: one hour in PACU
|
Four-point nausea and vomiting scale (0=no nausea; 1=mild nausea; 2=severe nausea requiring antiemetics; and 3=retching, vomiting, or both) was also evaluated
|
one hour in PACU
|
Extubation time
Time Frame: Up to 15 after discontinuation of anesthesia
|
Up to 15 after discontinuation of anesthesia
|
|
Surgical time
Time Frame: duration of surgery in minutes up to 3 hours
|
intraoperative
|
duration of surgery in minutes up to 3 hours
|
first verbal response time
Time Frame: up to 15 minutes
|
period from discontinuation of anesthesia 'time zero' to 1st verbal response in minutes
|
up to 15 minutes
|
complication of nasal block
Time Frame: From injection to 24 hours postoperative
|
including local anesthetic systemic toxicity, vascular injury, intravascular injection of local anesthetic, and local hematoma.
|
From injection to 24 hours postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2016
Primary Completion (Actual)
April 15, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
February 19, 2017
First Submitted That Met QC Criteria
March 1, 2017
First Posted (Actual)
March 3, 2017
Study Record Updates
Last Update Posted (Actual)
December 27, 2017
Last Update Submitted That Met QC Criteria
December 23, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Dyskinesias
- Psychomotor Disorders
- Psychomotor Agitation
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Adrenergic beta-Agonists
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Lidocaine
- Epinephrine
- Racepinephrine
- Epinephryl borate
Other Study ID Numbers
- 3-2-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Agitation States as Acute Reaction to Gross Stress
-
Hospital Infantil Albert SabinCompletedPain, Postoperative | Vomiting | Anesthesia | Agitation States as Acute Reaction to Exceptional StressBrazil
-
State University of New York - Upstate Medical...CompletedAgitated; State, Acute Reaction to Stress | Agitation,PsychomotorUnited States
-
Ain Shams UniversityCompletedAgitated; State, Acute Reaction to StressEgypt
-
Sakarya UniversityCompletedAgitated; State, Acute Reaction to StressTurkey
-
Maharishi Markendeswar University (Deemed to be...CompletedAnxiety | Agitated; State, Acute Reaction to Stress
-
IGC Pharma LLCRecruitingAggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive OutburstUnited States, Canada, Puerto Rico
-
Eye & ENT Hospital of Fudan UniversityCompletedAgitated; State, Acute Reaction to StressChina
-
United States Army Research Institute of Environmental...CompletedReaction to Severe Stress, UnspecifiedUnited States
Clinical Trials on External nasal nerve block
-
Severance HospitalRecruitingCough | Thoracic Surgery | Nerve BlockKorea, Republic of
-
Saint Francis CareCompleted
-
LifeBridge HealthRubin Institute for Advanced OrthopedicsRecruitingHip Osteoarthritis | Hip ArthropathyUnited States
-
Chicago Anesthesia Pain SpecialistsCompletedKnee ArthroplastyUnited States
-
Samsun UniversityCompletedPain | Pain, Postoperative | Pain, AcuteTurkey
-
University of California, San DiegoTerminatedFoot SurgeryUnited States
-
McGill University Health Centre/Research Institute...UnknownTotal Knee Arthroplasty Secondary to OsteoarthritisCanada
-
University of ParmaCompletedPostoperative Pain | Orthopedic Surgical ProceduresItaly
-
Clinique Medipole GaronneCompletedPrimary Total Knee ArthroplastyFrance
-
Seoul National University HospitalUnknownVideo Assisted Thoracoscopic SurgeryKorea, Republic of